128 related articles for article (PubMed ID: 31087053)
1. Treatment of Primary Aldosteronism With mTORC1 Inhibitors.
Trinh B; Hepprich M; Betz MJ; Burkard T; Cavelti-Weder C; Seelig E; Meienberg F; Kratschmar DV; Beuschlein F; Reincke M; Odermatt A; Hall MN; Donath MY; Swierczynska MM
J Clin Endocrinol Metab; 2019 Oct; 104(10):4703-4714. PubMed ID: 31087053
[TBL] [Abstract][Full Text] [Related]
2. Effects of Ramipril on the Aldosterone/Renin Ratio and the Aldosterone/Angiotensin II Ratio in Patients With Primary Aldosteronism.
Guo Z; Poglitsch M; Cowley D; Domenig O; McWhinney BC; Ungerer JPJ; Wolley M; Stowasser M
Hypertension; 2020 Aug; 76(2):488-496. PubMed ID: 32507039
[TBL] [Abstract][Full Text] [Related]
3. [Differences of blood plasma renin activity, angiotensin II and aldosterone levels in essential or secondary hypertension].
Song AL; Zeng ZP; Tong AL; Lu L; Chen S; Li M; Fu CL; Wang YH; Sun ML
Zhonghua Nei Ke Za Zhi; 2012 Apr; 51(4):294-8. PubMed ID: 22781950
[TBL] [Abstract][Full Text] [Related]
4. [Corticoid secretion in primary aldosteronism. II. The renin releasing test and the angiotensin II analog infusion test (author's transl)].
Nigawara K; Yagihashi Y; Kogawa T; Sugawara S; Kawamata A; Hitomi H; Tulachan Y; Funyu T; Terayama Y; Furusawa M; Morita S; Kido K; Tanaka T; Eba H
Nihon Naibunpi Gakkai Zasshi; 1980 Jan; 56(1):47-56. PubMed ID: 6987096
[TBL] [Abstract][Full Text] [Related]
5. [The effect of trilostane, a new inhibitor of adrenal steroid biosynthesis, on blood pressure, plasma aldosterone and other steroid hormones, serum potassium and plasma renin activity in primary aldosteronism (author's transl)].
Shigetomi S; Fukuchi S; Haruyama K; Yamazaki M
Nihon Naibunpi Gakkai Zasshi; 1982 Mar; 58(3):184-98. PubMed ID: 6212269
[TBL] [Abstract][Full Text] [Related]
6. Dopamine reduces aldosterone and 18-hydroxycorticosterone response to angiotensin II in patients with essential low-renin hypertension and idiopathic hyperaldosteronism.
Witzgall H; Lorenz R; von Werder K; Weber PC
Clin Sci (Lond); 1985 Mar; 68(3):291-9. PubMed ID: 3882312
[TBL] [Abstract][Full Text] [Related]
7. Aldosterone synthase inhibition with LCI699: a proof-of-concept study in patients with primary aldosteronism.
Amar L; Azizi M; Menard J; Peyrard S; Watson C; Plouin PF
Hypertension; 2010 Nov; 56(5):831-8. PubMed ID: 20837883
[TBL] [Abstract][Full Text] [Related]
8. Diagnostic value of the post-captopril test in primary aldosteronism.
Castro OL; Yu X; Kem DC
Hypertension; 2002 Apr; 39(4):935-8. PubMed ID: 11967253
[TBL] [Abstract][Full Text] [Related]
9. Suppression of Aldosterone Secretion After Recumbent Saline Infusion Does Not Exclude Lateralized Primary Aldosteronism.
Cornu E; Steichen O; Nogueira-Silva L; Küpers E; Pagny JY; Grataloup C; Baron S; Zinzindohoue F; Plouin PF; Amar L
Hypertension; 2016 Oct; 68(4):989-94. PubMed ID: 27600182
[TBL] [Abstract][Full Text] [Related]
10. Effect of angiotensin II and converting enzyme inhibitor (captopril) on blood pressure, plasma renin activity and aldosterone in primary aldosteronism.
Mantero F; Fallo F; Opocher G; Armanini D; Boscaro M; Scaroni C
Clin Sci (Lond); 1981 Dec; 61 Suppl 7():289s-293s. PubMed ID: 7032817
[TBL] [Abstract][Full Text] [Related]
11. Additive effects of combined angiotensin-converting enzyme inhibition and angiotensin II antagonism on blood pressure and renin release in sodium-depleted normotensives.
Azizi M; Chatellier G; Guyene TT; Murieta-Geoffroy D; Ménard J
Circulation; 1995 Aug; 92(4):825-34. PubMed ID: 7641363
[TBL] [Abstract][Full Text] [Related]
12. [Aldosterone/renin ratio in the diagnosis of primary aldosteronism].
Ríos MC; Izquierdo A; Sotelo M; Honnorat E; Rodríguez Cuimbra S; Catay E; Popescu BM
Medicina (B Aires); 2011; 71(6):525-30. PubMed ID: 22167725
[TBL] [Abstract][Full Text] [Related]
13. Exaggerated blood pressure response to angiotensin II in patients with Cushing's syndrome due to adrenocortical adenoma.
Yasuda G; Shionoiri H; Umemura S; Takasaki I; Ishii M
Eur J Endocrinol; 1994 Dec; 131(6):582-8. PubMed ID: 7804440
[TBL] [Abstract][Full Text] [Related]
14. The aldosterone/renin ratio as a screening test for primary aldosteronism.
Rayner BL; Opie LH; Davidson JS
S Afr Med J; 2000 Apr; 90(4):394-400. PubMed ID: 10957926
[TBL] [Abstract][Full Text] [Related]
15. [Influence of angiotensin on the secretion of aldosterone in idiopathic hyperaldosteronism].
Salvador M; Chamontin B; Rostaing L; Salva P
Arch Mal Coeur Vaiss; 1987 Jun; 80(6):992-4. PubMed ID: 3117000
[TBL] [Abstract][Full Text] [Related]
16. [Mechanism of inhibition of aldosterone secretion by a Ca2+ channel blocker in patients with essential hypertension and patients with primary aldosteronism].
Yokoyama T; Shimamoto K; Iimura O
Nihon Naibunpi Gakkai Zasshi; 1995 Nov; 71(7):1059-74. PubMed ID: 8582487
[TBL] [Abstract][Full Text] [Related]
17. Primary aldosteronism: effects of inhibition of ACTH and potassium administration on plasma aldosterone concentration.
Ganguly A; Luetscher JA; Weinberger MH
Clin Exp Hypertens A; 1982; 4(9-10):1695-714. PubMed ID: 6291813
[TBL] [Abstract][Full Text] [Related]
18. Effect of bromocriptine treatment on the aldosterone response to angiotensin II and adrenocorticotropin in idiopathic hyperaldosteronism.
Wisgerhof M; Mellinger RC
J Clin Endocrinol Metab; 1985 Jul; 61(1):192-5. PubMed ID: 2987293
[TBL] [Abstract][Full Text] [Related]
19. Seated saline suppression testing for the diagnosis of primary aldosteronism: a preliminary study.
Ahmed AH; Cowley D; Wolley M; Gordon RD; Xu S; Taylor PJ; Stowasser M
J Clin Endocrinol Metab; 2014 Aug; 99(8):2745-53. PubMed ID: 24762111
[TBL] [Abstract][Full Text] [Related]
20. [Plasma aldosterone levels in primary aldosteronism. 1. Renin-angiotensin system and aldosterone].
Fukuchi S; Takenouchi T; Nakajima K
Nihon Naibunpi Gakkai Zasshi; 1973 May; 49(5):781-7. PubMed ID: 4353260
[No Abstract] [Full Text] [Related]
[Next] [New Search]
